MedPath

The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Tourette Syndrome

Early Phase 1
Conditions
Tourette Syndrome
Interventions
Device: deep brain stimulation (DBS)
Registration Number
NCT02253498
Lead Sponsor
Beijing Pins Medical Co., Ltd
Brief Summary

The purpose of this clinical study is to verify the long term effectiveness and safety of a bilateral deep brain stimulation (DBS) produced by Beijing PINS Medical Co., Ltd. as a treatment option for patients with cognitive, behavioral, and functional disability of Tourette Syndrome.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  1. Subject is aged 18 or older
  2. Patient Group with Tourette's syndrome, Diagnosis of Tourette Syndrome by DSM-IV
Exclusion Criteria
  1. Major Depressive Episode within the previous 6 months
  2. Schizophrenia or other psychotic disorder.Participate in other clinical trial;
  3. Has a life expectancy of < 1 year.
  4. The investigator and/or enrollment review committee, would preclude participation in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham Stimulationdeep brain stimulation (DBS)placebo
Deep Brain Stimulationdeep brain stimulation (DBS)Deep Brain Stimulation is on
Primary Outcome Measures
NameTimeMethod
Modified Rush Video Rating Scale (mRVRS)12 month
Secondary Outcome Measures
NameTimeMethod
Tourette Syndrome Symptom List (TSSL)12 month
SF-3612 month
© Copyright 2025. All Rights Reserved by MedPath